Effective by end December, 2023, stool culture (i.e., routine stool C&S) will be replaced by the Infectious Diarrhea Panel (IDP) test, which is a molecular test capable of simultaneously detecting the majority of bacterial, viral, and parasitic causes of infectious diarrhea from a single sample. This test will be performed any time stool culture, stool ova and parasite exam, or stool virus testing is requested, and requires conversion from current Cary-Blair collection containers to the Copan FecalSwab. The test will be conducted using the Seegene AllplexTM Gastrointestinal Panel Assays, which have been validated for clinical use by Dynacare.
Read More: Testing Update: Implementation of Infectious Diarrhea Panel and FecalSwab Collection Devices for Detection of Enteric Pathogens - (BC Only)